Q2 EPS Estimate for Procter & Gamble Reduced by Analyst

Procter & Gamble Company (The) (NYSE:PG) – Equities researchers at Zacks Research cut their Q2 2027 earnings per share (EPS) estimates for shares of Procter & Gamble in a report issued on Thursday, November 5th. Zacks Research analyst Team now expects that the company will earn $1.80 per share for the quarter, down from their prior forecast of $1.88. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.99 per share. Zacks Research also issued estimates for Procter & Gamble’s Q3 2027 earnings at $1.63 EPS, Q4 2027 earnings at $1.53 EPS, FY2027 earnings at $6.96 EPS, Q1 2028 earnings at $2.11 EPS, Q2 2028 earnings at $1.98 EPS, Q3 2028 earnings at $1.73 EPS, Q4 2028 earnings at $1.59 EPS, FY2028 earnings at $7.41 EPS, Q1 2029 earnings at $2.25 EPS and FY2029 earnings at $7.91 EPS.

Several other research firms also recently weighed in on PG. DZ Bank downgraded shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 27th. Evercore upgraded Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price target for the company in a research note on Tuesday, October 6th. HSBC lowered Procter & Gamble from a “buy” rating to a “hold” rating and lowered their price objective for the company from $182.00 to $149.00 in a report on Thursday, July 30th. Argus cut Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. Finally, UBS Group set a $166.00 target price on Procter & Gamble in a report on Friday, October 23rd. Fifteen equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $170.57.

Procter & Gamble Trading Down 0.1%

NYSE PG opened at $167.15 on Friday. Procter & Gamble has a 12 month low of $137.62 and a 12 month high of $170.52. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53. The company has a market capitalization of $387.41 billion, a price-to-earnings ratio of 25.17, a price-to-earnings-growth ratio of 4.11 and a beta of 0.36. The company’s fifty day moving average price is $151.56 and its two-hundred day moving average price is $149.34.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, topping analysts’ consensus estimates of $1.89 by $0.11. The business had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The business’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.99 earnings per share.

Institutional Trading of Procter & Gamble

A number of institutional investors and hedge funds have recently made changes to their positions in PG. Baxter Bros Inc. bought a new position in Procter & Gamble in the second quarter valued at approximately $12,381,000. Empowered Funds LLC acquired a new position in Procter & Gamble during the second quarter valued at approximately $53,549,000. Capstone Capital Management Ltd bought a new stake in Procter & Gamble during the third quarter worth $991,000. Bank of America Corp DE bought a new stake in Procter & Gamble during the second quarter worth $3,850,628,000. Finally, Rokos Capital Management LLP acquired a new stake in shares of Procter & Gamble in the 1st quarter valued at $29,914,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Victor Aguilar sold 18,812 shares of the stock in a transaction dated Friday, October 30th. The shares were sold at an average price of $164.43, for a total transaction of $3,093,257.16. Following the sale, the insider owned 55,243 shares in the company, valued at $9,083,606.49. This represents a 25.40% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andre Schulten sold 33,624 shares of the firm’s stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $165.00, for a total transaction of $5,547,960.00. Following the completion of the transaction, the chief financial officer directly owned 65,618 shares in the company, valued at $10,826,970. This represents a 33.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 161,709 shares of company stock worth $26,244,058. Company insiders own 0.23% of the company’s stock.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.51%.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Zacks Research raised its FY2029 EPS estimate to $7.91 from $7.85 and lifted its Q1 2028 and Q1 2029 forecasts. The longer-term increases provide a modest positive counterpoint to reductions in other periods.
• Positive Sentiment: P&G’s latest reported quarter beat analyst expectations for earnings and revenue, with sales up 4% year over year. Demand for dependable dividend-paying consumer-staples stocks has also supported interest in the shares.
• Neutral Sentiment: P&G will webcast its November 19 Investor Day, where executives are expected to discuss strategy and the company’s long-term transformation. Investors may look for updates on growth plans and execution. Article: P&G Investor Day webcast
• Negative Sentiment: Zacks Research trimmed several nearer-term estimates, including FY2027 EPS to $6.96 from $6.97 and FY2028 to $7.41 from $7.42; multiple quarterly forecasts for 2027–28 were also reduced. The small cuts suggest somewhat softer expectations for those periods.
• Negative Sentiment: CFO Andre Schulten sold 33,624 shares for about $5.55 million, reducing his direct holding by roughly 34%. Insider sales can weigh on sentiment, though they do not necessarily indicate a change in the company’s outlook. Article: CFO share sale

Procter & Gamble Company Profile